Cargando…

A reappraisal of corticosteroids use for COVID-19

Detalles Bibliográficos
Autores principales:	Pati, Ilaria, Masiello, Francesca, Pupella, Simonetta, Cruciani, Mario, De Angelis, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378266/ https://www.ncbi.nlm.nih.gov/pubmed/36008208 http://dx.doi.org/10.1016/j.ejim.2022.08.019

Ejemplares similares

Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis
por: Cruciani, Mario, et al.
Publicado: (2021)

Correction: Cruciani et al. Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis. Diagnostics 2021, 11, 1645
por: Cruciani, Mario, et al.
Publicado: (2021)

Efficacy and Safety of Pathogen-Reduced Platelets Compared with Standard Apheresis Platelets: A Systematic Review of RCTs
por: Pati, Ilaria, et al.
Publicado: (2022)

Chagas Disease and Transfusion Risk in Italy: The Results of a National Survey
por: Pati, Ilaria, et al.
Publicado: (2022)

Hyperimmune Globulins for the Management of Infectious Diseases
por: Pati, Ilaria, et al.
Publicado: (2023)

COVID-19, corticosteroids and public health: a reappraisal
por: Fernandes, M., et al.
Publicado: (2021)

How Safe Is COVID-19 Convalescent Plasma?
por: Franchini, Massimo, et al.
Publicado: (2021)

Corticosteroids and rehabilitation in COVID-19 survivors
por: Lal, Amos, et al.
Publicado: (2021)

Opisthorchiasis, hypercholesterolemia, and cholangiocarcinoma: A reappraisal
por: Joob, Beuy, et al.
Publicado: (2017)

Clinical Audit: Time for a Reappraisal?
por: Rigge, Marianne
Publicado: (1996)

Performance indicators in ART: time for a reappraisal?
por: Sbracia, Marco, et al.
Publicado: (2021)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

Unresolved questions about the treatment of COVID-19 with corticosteroids()
por: Corral-Gudino, Luis, et al.
Publicado: (2021)

The association between corticosteroid uses and mortality among severe COVID-19 patients
por: Tang, Hung-Jen, et al.
Publicado: (2021)

Reply: Performance indicators in ART: time for a reappraisal?
por: Vlaisavljevic, Veljko, et al.
Publicado: (2022)

Reliability of SARS-CoV-2 serological testing for influencing public health policies: A reappraisal
por: Lippi, Giuseppe, et al.
Publicado: (2023)

Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022)

The association between corticosteroids and aspergillosis among COVID-19 patients
por: Chang, Yi-Hsin, et al.
Publicado: (2023)

Mental health insurance and attempted suicide: Need for a reappraisal
por: Sarkhel, Sujit
Publicado: (2021)

Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19
por: Goursaud, Suzanne, et al.
Publicado: (2020)

Use of corticosteroid injections in current COVID pandemic – Time to rethink!!
por: Rajakulasingam, Ramanan, et al.
Publicado: (2020)

The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids
por: Shokri, Somayeh, et al.
Publicado: (2022)

In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity
por: Nasa, Prashant, et al.
Publicado: (2022)

Corticosteroid therapy in COVID-19 patients: Don’t forget venous thromboembolism
por: Roncon, Loris, et al.
Publicado: (2021)

The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients
por: Jia, Xinyu, et al.
Publicado: (2021)

Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
por: FakhriRavari, Alireza, et al.
Publicado: (2021)

Corticosteroids in COVID-19: A double-edged sword – a retrospective study
por: Maia, R., et al.
Publicado: (2022)

Corticosteroids in COVID-19: A double-edged sword – a retrospective study
por: Maia, R., et al.
Publicado: (2022)

Hormonal therapies and venous thrombosis: considerations for prevention and management—a reappraisal
por: Douxfils, Jonathan, et al.
Publicado: (2023)

Antenatal corticosteroids: a reappraisal of the drug formulation and dose
por: Jobe, Alan H., et al.
Publicado: (2020)

Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids
por: John, Teny M., et al.
Publicado: (2020)

Use of the lung ultrasound score in monitoring COVID-19 patients: it’s time for a reappraisal
por: Vetrugno, Luigi, et al.
Publicado: (2021)

Exposure history and molecular epidemiology of SARS-CoV-2: A reappraisal
por: Joob, Beuy, et al.
Publicado: (2023)

What can we learn about corticosteroid therapy as a treatment for COVID-19?
por: Tang, J.
Publicado: (2020)

A case of shock after 10 days systemic corticosteroid therapy for COVID-19
por: Uemura, Keiko, et al.
Publicado: (2021)

Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?
por: van Berkel, Miranda, et al.
Publicado: (2020)

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Fang, Xiaowei, et al.
Publicado: (2020)

Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy
por: Crisan-Dabija, Radu, et al.
Publicado: (2021)

Prevalence and risk factors for hepatitis E virus infection in blood donors: a nationwide survey in Italy, 2017 to 2019
por: Spada, Enea, et al.
Publicado: (2022)

DO INDIAN RESEARCHERS READ INDIAN RESEARCH? A REAPPRAISAL, FOUR YEARS LATER
por: JILOHA, R.C.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_viv3opj7pcjncaivfb5mn27qca